Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00693550 · ClinicalTrials.gov registry record
Contact Allergies to Dental Metal as a Possible Risk Factor for Oral Cancer
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 115
- Enrollment target
NCT00693550: Completed study, sponsored by Mayo Clinic.
NCT00693550 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 115 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00693550 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 115 participants
- Enrollment target
Study Summary
RATIONALE: Gathering information about allergies to metals may help doctors learn whether having an allergy to metal used in dental work increases the risk of developing oral cancer. PURPOSE: This clinical trial is studying contact allergies to dental metal as a possible risk factor for oral cancer.
Interventions
- OTHER metal patch tests
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2000-08 |
| Est. Completion | 2009-01 |
What the finished NCT00693550 record still lists
NCT00693550 is an observational study that tracks outcomes without assigning an intervention. The registered 115 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which metal patch tests is the first listed.
NCT00693550 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00693550 about?
NCT00693550 is a clinical study titled "Contact Allergies to Dental Metal as a Possible Risk Factor for Oral Cancer". RATIONALE: Gathering information about allergies to metals may help doctors learn whether having an allergy to metal used in dental work increases the risk of developing oral cancer. PURPOSE: This clinical trial is studying contact allergies to dental metal as a possible risk factor for oral cancer...
What is the current status of trial NCT00693550?
This trial is currently completed. The enrollment target is 115 participants. The study started on 2000-08. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00693550?
The interventions under investigation include: metal patch tests (OTHER).
Who is sponsoring clinical trial NCT00693550?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02346929 · 115 participants · NA
Hematoma Block for Distal Radius Fracture
- NCT03394365 · 115 participants · Phase 3
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- NCT03907475 · 115 participants · Phase 2
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
- NCT05086692 · 115 participants · Phase 1
A Beta-only IL-2 ImmunoTherapY Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia